Your browser doesn't support javascript.
loading
Intestinal Spirochetosis: To Treat or Not to Treat.
Ho, Kimberly; Xu, Joseph; Katz, Seymour; Sarkar, Suparna A; Mujeeb Ullah, Ateeqa.
Afiliação
  • Ho K; Department of Pathology, New York University (NYU) Langone Health, Mineola, USA.
  • Xu J; Department of Internal Medicine, University of California Davis, Sacramento, USA.
  • Katz S; Department of Internal Medicine, New York University (NYU) Langone Health, Mineola, USA.
  • Sarkar SA; Department of Pathology and Laboratory Medicine, New York University (NYU) Langone Health, Mineola, USA.
  • Mujeeb Ullah A; Department of Pathology and Laboratory Medicine, New York University (NYU) Langone Health, Mineola, USA.
Cureus ; 16(1): e53248, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38425640
ABSTRACT
Spirochete colonization of the gastrointestinal tract is a poorly understood phenomenon presenting with varying signs and symptoms. Due to the lack of a unified approach and its varying presentations, the management decision for intestinal spirochetosis (IS) has always been challenging. While metronidazole is the commonly preferred antimicrobial treatment, it remains unclear if therapeutic intervention is indicated for everyone, especially asymptomatic patients. We present three patients, diagnosed with IS. They presented with varying demographics, clinical presentations, and past medical histories and underwent different clinical managements. Our decisions for treatment not only included presenting symptoms but also factors like history of pre-existing gastrointestinal diseases, age, and immune status.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos